Nevirapine (Viramune): News
- Changes in Viramune XR Tablets for Kids (January/February 2013)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- FDA Approval of Generic ARVs: Nevirapine and Combivir Now Off-Patent in the U.S. (May/June 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves Generic Formulations of Lamivudine and Zidovudine Tablets and Nevirapine Tablets and Oral Suspension (May 25, 2012)
From U.S. Food and Drug Administration
 Generic Nevirapine Now Available -- But the Big One Is Next Year (May 25, 2012)
From Journal Watch
On TheBodyPRO.com
- Nevirapine Prolonged Release Once-Daily Formulation Available in the UK (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves Extended-Release Version of HIV Drug (April 6, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- FDA Approves Nevirapine XR (March/April 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Announces Approval of Once-Daily Form of Viramune (Nevirapine) (March 28, 2011)
From U.S. Food and Drug Administration
- Switching to Viramune Is Possible at Higher CD4s (February 1, 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- New Assistance Program Helps HIVers Pay for Viramune (October 7, 2009)
From TheBody.com
- Summary of FDA Advisory on Nevirapine in Women With a CD4 Count Over 250 (February 28, 2005)
In AIDS Treatment News, from AIDS Treatment News
- FDA Public Health Advisory for Nevirapine (Viramune) (January 19, 2005)
From U.S. Food and Drug Administration
- Nevirapine Misinformation: Will It Kill? (December 31, 2004)
From AIDS Treatment News
- South Africa Drops Recommendation of Single-Dose Nevirapine Monotherapy for Pregnant Women (July 14, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Nevirapine Precautions Published (February 27, 2004)
New instructions provide information on who is most at risk for rare but serious liver-related side effects.
In AIDS Treatment News, from AIDS Treatment News
- Nevirapine-Based Fixed-Dose Combination Antiretrovirals in Resource-Limited Settings (May 2003)
Excerpted from HIV & AIDS Treatment in Practice.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Pharmaceutical Giant to Let Generic Company Manufacture Its AIDS Drug (October 15, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Boehringer Ingelheim Pharmaceuticals Withdraws AIDS Drug Application (March 25, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Let Nevirapine Do What It Does Best (March 2002)
Why recent doubts about widespread use of the drug are unfounded.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- St. John's Wort Found to Lower Nevirapine Levels (March 2, 2001)
From Canadian AIDS Treatment Information Exchange
- Severe Nevirapine Rash Found More Likely in Women Than Men (January 22, 2001)
From Canadian AIDS Treatment Information Exchange
|
Advertisement
|
Email
Glossary
